What to know about Palantir's engineer-led sales strategy — Positive
PLTR CNBC Television — August 05, 2025CNBC's “Money Movers” team discusses Palantir's second-quarter earnings report as the stock hits a record high after the company reported its first $1 billion revenue quarter with Michal Lev-Ram, CNBC contributor and contributing editor at Fortune.

Zoetis Inc. (NYSE:ZTS ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Kristin C. Peck - CEO & Director Steven Frank - Vice President of Investor Relations Wetteny N.

INVESTOR ALERT: Investigation of agilon health, inc. (AGL) Announced by Holzer & Holzer, LLC — Neutral
AGL GlobeNewsWire — August 05, 2025ATLANTA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether agilon health, inc. (“agilon health” or the “Company”) (NYSE: AGL) complied with federal securities laws. On August 4, 2025, agilon health announced that its CEO and President had resigned and that it was “suspending its previously issued full-year 2025 financial guidance and related assumptions.” Following this news, the price of the Company's stock dropped.

Axon jumps 14% after TASER maker tops results and boosts outlook on security needs — Positive
AXON CNBC — August 05, 2025Axon shares jumped after the TASER maker beat Wall Street's second-quarter estimates and hiked its guidance. The security solutions company also hiked guidance for the year, saying it now expects revenues of $2.65 billion to $2.73 billion.

Gold bulls buy the dip as U.S. equities sell off — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — August 05, 2025Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

IBKR July 2025 DARTs Rise: Is Product Suite Expansion a Catalyst? — Positive
IBKR Zacks Investment Research — August 05, 2025Interactive Brokers' July 2025 DARTs rally 27% y/y as new products and global expansions drive trading activity.

AMAT vs. TSM: Which Semiconductor Stock is the Better Buy? — Positive
AMAT TSM Zacks Investment Research — August 05, 2025Applied Materials and Taiwan Semiconductor are key AI chip players, but AMAT's growth outlook and earnings trajectory stand out for investors.

Toll Brothers Apartment Living® Breaks Ground on The Airedale, a New Luxury Apartment Community in Charlotte — Neutral
TOL GlobeNewsWire — August 05, 2025The three-story, 348-unit community is Toll Brothers Apartment Living's first luxury multifamily development in North Carolina The three-story, 348-unit community is Toll Brothers Apartment Living's first luxury multifamily development in North Carolina

Gladstone Capital (GLAD) Q3 2025 Earnings Call Transcript — Neutral
GLAD Seeking Alpha — August 05, 2025Gladstone Capital. (NASDAQ:GLAD ) Q3 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Catherine Gerkis - Director of Investor Relations & ESG David John Gladstone - Chairman & CEO Nicole Schaltenbrand - CFO & Treasurer Robert L.

Data Center REITs: Own The Real Estate Behind AI — Positive
AAPL DLR EQIX Seeking Alpha — August 05, 2025AI-driven demand is transforming data center REITs, with DLR and EQIX well-positioned despite recent volatility and short-term setbacks in 2025. Long-term secular growth remains intact, as AI use cases and power needs are set to expand dramatically through 2030, driving further rent and revenue growth. Recent disruptions, such as DeepSeek's efficient AI model and Microsoft's pullback, have created buying opportunities for active managers with conviction in the sector.

Banco Santander Chile Is Fully-Priced In A Cyclical Top In Credit — Positive
BSAC Seeking Alpha — August 05, 2025Banco Santander Chile is benefiting from recent rate cuts, boosting margins and profitability, but this tailwind is likely ending. Credit quality is deteriorating, and macro headwinds—like weakening exports and rising US tariffs—pose risks to future earnings. Despite solid recent results, loan growth is stagnant and further margin expansion appears unlikely as rates stabilize.

Core Scientific shareholders push back on CoreWeave's $9B takeover offer: report — Negative
CORZ CRWV Proactive Investors — August 05, 2025CoreWeave (NASDAQ:CRWV)'s $9 billion all-stock acquisition of data center operator Core Scientific (NASDAQ:CORZ) is facing shareholder resistance, with major investors saying they may vote against the deal unless its terms are updated, according to a Financial Times report. The FT, citing people familiar with the matter, said the pushback stems from concerns that the current offer undervalues Core Scientific and exposes its investors to unnecessary downside risk.

Marriott Stock Up as Q2 Earnings Beat Estimates, RevPAR Rises Y/Y — Positive
MAR Zacks Investment Research — August 05, 2025MAR's second-quarter results reflect strong travel demand and expansion momentum despite macro uncertainty.

AGNC Investment's Q2 BVPS Declines Y/Y: What's the Reason Behind it? — Neutral
AGNC Zacks Investment Research — August 05, 2025AGNC's Q2 book value per share slid 7% as widening mortgage spreads and MBS losses pressured portfolio valuations.

Shareholder Alert: The Ademi Firm investigates whether Y-mAbs Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders — Neutral
YMAB PRNewsWire — August 05, 2025MILWAUKEE , Aug. 5, 2025 /PRNewswire/ -- The Ademi Firm is investigating Y-mAbs (NASDAQ: YMAB) for possible breaches of fiduciary duty and other violations of law in its transaction with SERB Pharmaceuticals. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.

REPL DEADLINE: Replimune Group Investors Should Contact Block & Leviton By September 22nd To Join Securities Fraud Lawsuit — Neutral
REPL GlobeNewsWire — August 05, 2025Block & Leviton reminds investors that a securities fraud lawsuit has been filed against Replimune Group (Nasdaq: REPL). Investors should contact the firm.

Tesla faces shareholder lawsuit after Robotaxi test raises safety concerns — Negative
TSLA Proactive Investors — August 05, 2025Tesla Inc (NASDAQ:TSLA) and its CEO Elon Musk were sued by shareholders who accused the electric vehicle maker of securities fraud for allegedly concealing safety risks associated with its self-driving vehicles, including the recently tested Robotaxi. The proposed class action, filed late Monday in federal court in Austin, Texas, claims Tesla misled investors by overstating the capabilities of its autonomous driving technology and failing to disclose operational flaws that could compromise safety and violate traffic laws.

Palantir Hits $1B: It'll Get Harder To Impress From Here — Positive
PLTR Seeking Alpha — August 05, 2025Palantir Technologies Inc. delivered a blowout quarter, surpassing $1B in revenue months ahead of schedule, and America's defense spend (and commercial spend) is to thank. We don't think Palantir is going anywhere; it's safe to say they've carved a sticky place for themselves at the intersection of AI, data analytics, and defense. U.S. revenue, about 73% of total sales, is on a bullet train, but the international side of the business is what we think will drive the stock that extra mile.

Carvana's Return To Profitable Growth Is Overbought - Upward Momentum Faltering — Positive
CVNA Seeking Alpha — August 05, 2025Carvana's promising performance metrics highlight its ongoing reversal from prior pandemic pains, as they competently monetize the used car inventories and in-house loan sales. These reasons may also be why the management has felt confident to offer robust FY 2025 adj. EBITDA guidance, with the cash flows already flowing into its healthier balance sheet. With used cars cheaper than new cars, we believe that CVNA may continue to outperform in the near term for so long that demand remains healthy.

Expedia Gears Up to Post Q2 Earnings: What's in Store for the Stock? — Positive
EXPE Zacks Investment Research — August 05, 2025EXPE eyes Q2 revenue growth despite U.S. softness, with B2B strength and cost cuts driving profit margin gains.
